Werba Rubin Papier Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.54M Buy
1,280
+8
+0.6% +$8.17K 0.19% 69
2026
Q1
$1.17M Buy
1,272
+473
+59% +$480K 0.16% 74
2025
Q4
$859K Buy
799
+117
+17% +$112K 0.23% 69
2025
Q3
$520K Buy
682
+79
+13% +$58.8K 0.08% 120
2025
Q2
$470K Buy
603
+64
+12% +$49.7K 0.09% 117
2025
Q1
$445K Buy
539
+75
+16% +$62.4K 0.1% 109
2024
Q4
$358K Sell
464
-44
-9% -$36.4K 0.08% 123
2024
Q3
$450K Buy
508
+113
+29% +$102K 0.11% 108
2024
Q2
$358K Buy
+395
New +$316K 0.1% 110

Other funds holding LLY

Werba Rubin Papier Wealth Management's LLY Position: Q2 2026 in Review

Werba Rubin Papier Wealth Management increased its Eli Lilly (LLY) stake by 0.63% in Q2 2026, buying an estimated $8.17K and bringing the position to 1,280 shares worth $1.54M. The position accounts for 0.19% of the portfolio, ranked #69.

Werba Rubin Papier Wealth Management first reported a position in LLY in Q2 2024 and has held it in 9 quarters since. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Werba Rubin Papier Wealth Management held 1,280 shares of Eli Lilly worth $1.54M as of Q2 2026.
  • Werba Rubin Papier Wealth Management bought 8 Eli Lilly shares in Q2 2026, an estimated $8.17K.
  • Eli Lilly made up 0.19% of Werba Rubin Papier Wealth Management's portfolio in Q2 2026, its #69 holding.
  • Werba Rubin Papier Wealth Management first reported a position in Eli Lilly in Q2 2024 and has held it in 9 quarters since.
  • 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Werba Rubin Papier Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.